血液透析患者输血前后抗-HCV的追踪检测

A Follow-up Examination of Anti-HCV in Haemodialysis Patients Before and After Blood Transfusion

目的 了解血液透析患者输血前后 HCV感染情况。 方法 采用 EL ISA法进行抗 - HCV检测。 结果 116例血液透析患者抗 - HCV阳性率为 13.79% ,输血组输血前与未输血组比较无显著性差异 ,追踪检测输血后 6、12、18、2 4个月病例 ,随着血液透析时间延长 ,抗 - HCV阳性率增高 ,但输血组与未输血组比较仍无差异。 结论 血液透析患者与输血前后抗 - HCV阳性率无明显差异 ,输血不增加感染

Objective To know about the situation of HCV infection in haemodialysis patients before and after blood transfusion. Methods ELISA was adopted to detect anti-HCV. Result The positive rate of anti-HCV was 13.79% in 116 haemodialysis cases, showing no significant difference between blood transfusion group and non blood transfusion group. The positive rate of anti-HCV rises with the interval after baemodialysis in cases 6,12,8 and 24 months after receiving blood transfusion. No difference was demonstrated in blood transfusion and non-blood transfusion group. Conclusion The positive rate of anti-HCV has no significant difference in haemodialysis patients before and after blood transfusion. Blood transfusion doesn't increase the risk of HCV infection.